Clinical Trial

EEG Changes After rTMS Stimulation

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to explore the brain's electrical reactivity, monitored using EEG, following the EXOMIND (BTL-699-2) stimulation across various stimulation locations. The main question it aims to answer is: What is the brain's cortical electrical reactivity, monitored using EEG, following the EXOMIND (BTL-699-2) stimulation across various stimulation locations? Participants will be asked to: * Undergo 1 treatment visit * Undergo electroencephalography (EEG) measurements * Complete Therapy Comfort Questionnaires
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-09-11; most recent amendment 2026-03-27.
Status change: Recruiting → Completed 2026-03-27
Status change: Not Yet Recruiting → Recruiting 2025-09-22
Trial Details
NCT Number NCT07179224
Lead Sponsor BTL Industries Ltd.
Conditions Brain Electrical Reactivity to BTL-699-2 Stimulation
Enrollment 12 participants
Start Date 2025-09-17
Primary Completion 2025-10-29 (estimated)
Study Completion 2025-10-29 (estimated)
Updated on ClinicalTrials.gov 2026-03-30